对比增强超声与MRI肝脏影像报告和数据系统(LI-RADS)对肝细胞癌风险患者肝脏病灶分类的诊断效能
本研究回顾性分析84例患者86个肝脏病灶的CEUS和MRI数据,按LI-RADS分类,以随访和病理为标准。CEUS与MRI的AUC分别为0.876和0.873,无显著差异(Z=0.050,p=0.960);CEUS LR-5特异度显著高于MRI(93.94% vs 90.9%,p=0.006)。CEUS LI-RADS是有效诊断工具,观察者内可靠性高。
要点
- CEUS LI-RADS与MRI LI-RADS对HCC的诊断效能相当,AUC无显著差异。
- CEUS LR-5特异度显著高于MRI LR-5(93.94% vs 90.9%,p=0.006)。
- CEUS LI-RADS观察者内一致性:动脉期高增强几乎完美(k=0.870),廓清和分类均属高度一致。
核心结论
- CEUS LI-RADS是有效的HCC诊断工具,观察者内可靠性高,诊断效能与MRI LI-RADS相当,且CEUS LR-5特异度显著更高。
研究设计与样本
- 回顾性分析84例患者86个肝脏病灶的CEUS和MRI数据,按LI-RADS方案分类,以随访结果和病理 Findings 为参考标准。
- 采用受试者工作特征(ROC)曲线分析计算曲线下面积(AUC),并计算LR-5诊断HCC的敏感度、特异度、准确率、阳性预测值和阴性预测值。
- 评估CEUS LI-RADS的观察者内一致性。
诊断标准与关键数值
- CEUS和MRI分别有42个病灶分类为LR-5。
- 参考标准下53个结节为HCC。
- CEUS的AUC为0.876,MRI的AUC为0.873,两者无显著差异(Z=0.050,p=0.960)。
- CEUS LR-5诊断HCC的敏感度75.47%、特异度93.94%、PPV 95.24%、NPV 70.45%、准确率82.56%;MRI LR-5分别为73.58%、90.9%、92.86%、68.18%、80.23%。
- CEUS与MRI特异度差异显著(p=0.006)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
AIM: To investigate the diagnostic efficacy of the contrast-enhanced ultrasound Liver Imaging Reporting and Data System (CEUS LI-RADS) for categorising hepatic observations in patients at risk of hepatocellular carcinoma (HCC) compared with magnetic resonance imaging (MRI) LI-RADS.
MATERIALS AND METHODS: CEUS and MRI data were analysed retrospectively according to the LI-RADS scheme. Follow-up results and pathological findings served as the reference standard. Receiver operating characteristic (ROC) curve analysis was used to reveal the area under the curve (AUC). The sensitivity, specificity, accuracy, and positive (PPV) and negative predictive values (NPV) of LR-5 for determining HCC were calculated. The intra-observer agreement of CEUS LI-RADS was also evaluated.
RESULTS: Eighty-four patients with 86 liver observations were enrolled. Forty-two observations were classified as LR-5 by CEUS and MRI, respectively. Based on the reference standard, 53 nodules were HCC. The AUCs were 0.876 for CEUS and 0.873 for MRI, without a significant difference (Z=0.050, p=0.960). The sensitivity, specificity, PPV, NPV, and accuracy of LR-5 was 75.47%, 93.94%, 95.24%, 70.45%, 82.56% with CEUS and 73.58%, 90.9%, 92.86%, 68.18%, 80.23% with MRI, respectively. There was a significant difference in specificity between CEUS and MRI (p=0.006). There was almost perfect agreement for arterial phase hyperenhancement (k=0.870), substantial agreement for washout (k=0.765) and CEUS LI-RADS category (k=0.787).
CONCLUSION: The CEUS LI-RADS scheme is an effective diagnostic tool for HCC with substantial intra-observer reliability. The diagnostic performance of CEUS LI-RADS for determining HCC was comparable to MRI LI-RADS, and the specificity of CEUS LR-5 was significantly higher.
引用
- Li S, Zhou L, Chen R, et al. Diagnostic efficacy of contrast-enhanced ultrasound versus MRI Liver Imaging Reporting and Data System (LI-RADS) for categorising hepatic observations in patients at risk of hepatocellular carcinoma. Clin Radiol. 2020. PMID: 33198943. doi:10.1016/j.crad.2020.10.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。